Research is being conducted on the genetic basis and molecular mechanisms of uveal melanoma metastasis, with a focus on prognosis. Studies are exploring various aspects, including the molecular mechanisms of the disease, potential therapeutic implications, and the role of certain regulators and biomarkers. The research appears to involve multiple approaches, including network pharmacology, multi-omics analysis, and single-cell omics, with some studies also investigating treatment options and resistance mechanisms.